The South Australian State Government funded Meningococcal B Immunisation Program provides free meningococcal B (Bexsero) vaccines for children and young people. The vaccination program includes children under 4 years of age and young adults from 17 years to under 21 years (commencing 1/2/19).
Children under 4 years
We offer the meningococcal B (Bexsero) immunisation for your child at their usual National Immunisation Program (NIP) vaccinations (4, 6, 12 and 18 months). Children not due for their NIP vaccinations, who are under the age of 4 years, will be eligible to receive the funded meningococcal B (Bexsero) immunisation in a catch-up clinic on Friday mornings. The number of doses of the meningococcal vaccination depends on the age that the vaccination course is commenced. If you would like your child to be vaccinated, please make a booking at our Meningococcal B vaccine clinic by calling us on (08) 7228 5818 during business hours.
Students in Years 10 and 11 will be offered vaccination through the School Immunisation Program, with an ongoing school program to offer vaccination to Year 10 students.
A catch-up program will be available for those aged 17 to less than 21 years of age, which ends 31 December 2019.
If you would like to arrange vaccination and are aged 17 to less than 21 years, please make a booking by calling us on (08) 7228 5818 during business hours.
Fever is a common side effect of this vaccination. About 1 in 4 children will have a fever of 38°C or more, and 1 in 10 a fever of 39°C or more degrees. This is highest within 6 hours of vaccination, and resolves within 3 days. It is recommended children less than 2 years of age receive a dose of paracetamol approximately 30 minutes before the immunisation to reduce the risk of fever. A further two doses of paracetamol can be given at 6 and 12 hours following vaccination, regardless of fever. This does not affect the effectiveness of the vaccination, but does halve the risk of high grade fever. Other common reactions to the vaccination include tenderness, swelling and redness at the injection site, irritability, sleepiness or crying.
For adolescents and adults the most common reported reactions are pain at the injection site, malaise and headache.
Please talk with our Practice Nurse Bridget, or our Doctors, for more information on the vaccination.
More information on the program and vaccination can be found at: